Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ironwood Pharmaceuticals Inc (NASDAQ:IRWD)

17.17
Delayed Data
As of Mar 27
 +0.03 / +0.18%
Today’s Change
9.06
Today|||52-Week Range
18.53
+12.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues66.0M54.4M66.1M87.5M
 
 
 
 
 
Cost of Goods Sold0.000.000.001.9M
 
 
Depreciation And Amortization2.8M3.6M5.4M-536.0K
 
 
 
 
 
 
Operating ExpensesGross Income63.2M50.8M60.7M86.1M
 
 
 
 
 
General Expenses65.2M66.1M80.3M90.9M
 
 
 
 
 
Other Operating Expenses0.000.000.00374.0K
 
 
Research And Development31.8M31.7M37.5M35.7M
 
 
 
 
 
Total Operating Expenses68.0M69.7M85.7M92.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.0M-15.3M-19.6M-5.1M
 
 
 
 
 
Extraordinary Credit0.003.1M4.5M2.1M
 
 
 
 
Extraordinary Charge-1.6M0.00-8.7M-1.2M
 
 
 
 
Interest Expense On Debt9.9M9.8M9.8M9.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.3M-21.7M-33.2M-13.5M
 
 
 
 
 
Net Income-13.3M-21.7M-33.2M-13.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS143.6M144.6M145.2M146.3M
 
 
 
 
 
Shares To Calculate EPS Diluted143.6M144.6M145.2M146.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.09-$0.15-$0.23-$0.09
 
 
 
 
 
EPS Diluted-$0.09-$0.15-$0.23-$0.09